ADENYLYL CYCLASE G BG STIMULATION AND OPIOID TOLERANCE
腺苷酸环化酶 G BG 刺激和阿片类药物耐受性
基本信息
- 批准号:6515664
- 负责人:
- 金额:$ 24.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-08-01 至 2004-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Adenylyl cyclase (AC) 'superactivation' has long held a central position in models of opioid tolerance. The enclosed application will explore a new, complementary hypothesis that opioid tolerance also results from changes in the consequences of opioid receptor activation of Gi. Specifically, it is postulated that chronic opioid treatment induces a shift from opioid receptor- Galphai inhibition to Gbetagamma (Gi-derived) stimulation of AC activity. This would result from the induction of Gbetagamma-stimulated ACs and increases in AC isoform-specific phosphorylation after chronic morphine. In chronic morphine-treated tissue and cell lines, stimulatory responsiveness of some AC isoforms, assessed in the absence of exogenous opioid, is significantly reduced. The switch from inhibitory to stimulatory opioid receptor signaling would compensate for this attenuated activity. Consequently, despite the continued presence of inhibitory concentrations of opioid, 'normal' activity of these isoforms would be maintained, i.e., opioid tolerance would ensue. Although the myenteric plexus has been of enormous value in formulating the above hypothesis, its proof will require the use of simpler, cell culture systems such as CHO and HEK 293 cell lines, stably transfected with the mu opioid receptor. The specific aims are: (1) Determine the effect of chronic opioid treatment on levels of mRNA encoding Gbetagamma-stimulated AC isoforms and AC protein. (2) Determine the effect of chronic opioid treatment on inhibitory vs stimulatory opioid receptor-AC signaling. (3) Determine if the chronic morphine-induced shift from inhibitory to stimulatory opioid receptor signaling is mediated via augmented Gbetagamma stimulation of AC. (4) Determine the specific AC isoform(s) (I, II, IV VII) and sites therein that manifest augmented phosphorylation following chronic morphine. Altered content of G proteins and opioid receptor coupling thereto has been a predominant focus of attempts to elucidate neurochemical underpinnings of tolerance. The formulation that chronic morphine induces changes in the relative abundance and phosphorylation state of specific AC isoforms which in turn alters the consequences of opioid receptor activation of Gi is novel. It represents a new approach to probing narcotic tolerance which could result in more effective pharmacotherapies for managing pain.
腺苷酸环化酶(AC)“超激活”长期以来在阿片类药物耐受性模型中占据中心地位。所附的申请将探索一个新的,互补的假设,阿片耐受性也由阿片受体激活Gi的后果的变化引起。具体来说,假设慢性阿片类药物治疗诱导阿片受体- Galphai抑制向gbetagama (gi衍生)刺激AC活性的转变。这可能是由于慢性吗啡后,β - γ刺激的AC和AC异构体特异性磷酸化的增加。在慢性吗啡处理的组织和细胞系中,在缺乏外源性阿片样物质的情况下,一些AC亚型的刺激反应性显着降低。从抑制性到刺激性阿片受体信号的转换将补偿这种减弱的活性。因此,尽管阿片类药物的抑制浓度持续存在,但这些同种异构体的“正常”活性将得到维持,即阿片类药物耐受性将随之而来。尽管肌丛在形成上述假设方面具有巨大的价值,但其证明将需要使用更简单的细胞培养系统,如CHO和HEK 293细胞系,稳定地转染mu阿片受体。具体目的是:(1)确定慢性阿片类药物治疗对gbetagama刺激的AC亚型和AC蛋白编码mRNA水平的影响。(2)确定慢性阿片治疗对抑制性和刺激性阿片受体- ac信号传导的影响。(3)确定慢性吗啡诱导的阿片受体信号从抑制性到刺激性的转变是否通过增强的谷丙酰胺刺激AC介导。(4)确定慢性吗啡后特异性AC异构体(I, II, IV, VII)及其中表现出增强磷酸化的位点。G蛋白含量的改变和与之耦合的阿片受体一直是试图阐明耐受性的神经化学基础的主要焦点。慢性吗啡诱导特异性AC亚型的相对丰度和磷酸化状态的变化,从而改变Gi的阿片受体激活的后果,这一说法是新的。它代表了一种探索麻醉耐受性的新方法,可以导致更有效的药物治疗来管理疼痛。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALAN R GINTZLER其他文献
ALAN R GINTZLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALAN R GINTZLER', 18)}}的其他基金
Alternatives to prescription opioids: a precision medicine approach to harnessing endogenous opioids for pain relief and circumvention of prescription opioid abuse
处方阿片类药物的替代品:利用内源性阿片类药物缓解疼痛和规避处方阿片类药物滥用的精准医学方法
- 批准号:
9303135 - 财政年份:2017
- 资助金额:
$ 24.58万 - 项目类别:
Sex-dependent expression and utilization of spinal mu- and kappa-opioid systems
脊髓 mu 和 kappa 阿片系统的性别依赖性表达和利用
- 批准号:
8449716 - 财政年份:2010
- 资助金额:
$ 24.58万 - 项目类别:
Sex-dependent expression and utilization of spinal mu- and kappa-opioid systems
脊髓 mu 和 kappa 阿片系统的性别依赖性表达和利用
- 批准号:
8248791 - 财政年份:2010
- 资助金额:
$ 24.58万 - 项目类别:
Sex-dependent expression and utilization of spinal mu- and kappa-opioid systems
脊髓 mu 和 kappa 阿片系统的性别依赖性表达和利用
- 批准号:
8077894 - 财政年份:2010
- 资助金额:
$ 24.58万 - 项目类别:
ADENYLYL CYCLASE G BG STIMULATION AND OPIOID TOLERANCE
腺苷酸环化酶 G BG 刺激和阿片类药物耐受性
- 批准号:
6378840 - 财政年份:1999
- 资助金额:
$ 24.58万 - 项目类别:
ADENYLYL CYCLASE G BG STIMULATION AND OPIOID TOLERANCE
腺苷酸环化酶 G BG 刺激和阿片类药物耐受性
- 批准号:
6606140 - 财政年份:1999
- 资助金额:
$ 24.58万 - 项目类别:
Adenylyl Cyclase GBetaGamma Stimulation and Opioid Tolerance
腺苷酸环化酶 GBetaGamma 刺激和阿片类药物耐受性
- 批准号:
7874579 - 财政年份:1999
- 资助金额:
$ 24.58万 - 项目类别:
Adenylyl Cyclase GBetaGamma Stimulation and Opioid Tolerance
腺苷酸环化酶 GBetaGamma 刺激和阿片类药物耐受性
- 批准号:
7653600 - 财政年份:1999
- 资助金额:
$ 24.58万 - 项目类别:
ADENYLYL CYCLASE G BG STIMULATION AND OPIOID TOLERANCE
腺苷酸环化酶 G BG 刺激和阿片类药物耐受性
- 批准号:
6174760 - 财政年份:1999
- 资助金额:
$ 24.58万 - 项目类别:
Adenylyl Cyclase GBetaGamma Stimulation and Opioid Tolerance
腺苷酸环化酶 GBetaGamma 刺激和阿片类药物耐受性
- 批准号:
7305483 - 财政年份:1999
- 资助金额:
$ 24.58万 - 项目类别:
相似海外基金
Neuroendocrine regulation of energy metabolism: role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the thermoregulatory cascade
能量代谢的神经内分泌调节:垂体腺苷酸环化酶激活多肽(PACAP)在温度调节级联中的作用
- 批准号:
RGPIN-2021-04040 - 财政年份:2022
- 资助金额:
$ 24.58万 - 项目类别:
Discovery Grants Program - Individual
Controlled Release of Pituitary Adenylate Cyclase Activating Polypeptide from a Hydrogel-Nanoparticle Delivery Vehicle for Applications in the Central Nervous System
从水凝胶-纳米粒子递送载体中控制释放垂体腺苷酸环化酶激活多肽,用于中枢神经系统的应用
- 批准号:
547124-2020 - 财政年份:2022
- 资助金额:
$ 24.58万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Controlled Release of Pituitary Adenylate Cyclase Activating Polypeptide from a Hydrogel-Nanoparticle Delivery Vehicle for Applications in the Central Nervous System
从水凝胶-纳米粒子递送载体中控制释放垂体腺苷酸环化酶激活多肽,用于中枢神经系统的应用
- 批准号:
547124-2020 - 财政年份:2021
- 资助金额:
$ 24.58万 - 项目类别:
Postgraduate Scholarships - Doctoral
Neuroendocrine regulation of energy metabolism: role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the thermoregulatory cascade
能量代谢的神经内分泌调节:垂体腺苷酸环化酶激活多肽(PACAP)在温度调节级联中的作用
- 批准号:
RGPIN-2021-04040 - 财政年份:2021
- 资助金额:
$ 24.58万 - 项目类别:
Discovery Grants Program - Individual
The Molecular Mechanism of the Secretion of the Bacterial Toxin Adenylate Cyclase
细菌毒素腺苷酸环化酶分泌的分子机制
- 批准号:
451966 - 财政年份:2021
- 资助金额:
$ 24.58万 - 项目类别:
Operating Grants
The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking
前额纹状体垂体腺苷酸环化酶激活多肽在过量和强迫性乙醇饮酒中的作用
- 批准号:
10455587 - 财政年份:2020
- 资助金额:
$ 24.58万 - 项目类别:
The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking
前额纹状体垂体腺苷酸环化酶激活多肽在过量和强迫性乙醇饮酒中的作用
- 批准号:
10261394 - 财政年份:2020
- 资助金额:
$ 24.58万 - 项目类别:
Diagnosis and therapeutic effect of neurally mediated syncope (NMS) using fluctuation of adenylate cyclase activity
利用腺苷酸环化酶活性波动对神经介导性晕厥(NMS)的诊断和治疗效果
- 批准号:
20K08498 - 财政年份:2020
- 资助金额:
$ 24.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pituitary adenylate cyclase-activating polypeptide 27 in the paraventricular thalamus and its projections: Role in ethanol drinking
室旁丘脑中的垂体腺苷酸环化酶激活多肽 27 及其预测:在乙醇饮用中的作用
- 批准号:
10380126 - 财政年份:2020
- 资助金额:
$ 24.58万 - 项目类别:
The role of prefrontostriatal Pituitary Adenylate Cyclase Activating Polypeptide in excessive and compulsive ethanol drinking
前额纹状体垂体腺苷酸环化酶激活多肽在过量和强迫性乙醇饮酒中的作用
- 批准号:
10662279 - 财政年份:2020
- 资助金额:
$ 24.58万 - 项目类别: